Answers are grounded in this paper and cite their sources.
Demonstrates inducible CYP2B1 and CYP2B2 expression in rat blood lymphocytes, indicating their potential utility as accessible biomarkers for hepatic drug metabolism.
Cytochrome P450 2B1 and 2B2, the major hepatic drug metabolizing enzymes belonging to CYP2 family and associated constitutive androstane receptor (CAR) were found to be expressed in peripheral blood lymphocytes (PBL) isolated from rats. As observed in liver, pretreatment of phenobarbital (PB) or phenytoin were found to increase the expression of CYP2B1, CYP2B2 and associated enzyme activity in PBL. Like in liver, blood lymphocyte CYP2B1/2B2 catalyzed the activity of 7-pentoxyresorufin O-dealkylase (PROD). The present data, demonstrating similarities in the regulation of blood lymphocyte CYP2B-isoenzymes with the liver enzymes, suggests that blood lymphocyte CYP2B-isoenzymes could be used as a biomarker to monitor tissue levels.
No takes yet. Share an insight, caveat, or question.
Saurabh et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: